Protective Effect of Ramipril Against Oxidant and Proinflammatory Cytokine Damage Induced by Ischemia-Reperfusion in Ovarian Tissue in Rats
Özet
Background: It is known that the increase in oxidants and proinflammatory cytokines, as well as the decrease in antioxidants, play a role in ovarian ischemia-reperfusion (I/R) injury. The antioxidant and anti-inflammatory properties of ramipril have been studied in various diseases. This study aims to investigate the effect of ramipril on I/R-induced ovarian damage in rats. Methods: Rats were divided into healthy (HG), sham (SG), ovary I/R (OIR), and ramipril + ovary I/R (ROIR) groups (n = 6/each group). One hour before the surgical procedures, ROIR was given 2 mg/kg ramipril. The lower abdomen of the SG, OIR, and ROIR was surgically opened. Right ovarian tissues of OIR and ROIR were subjected to 2 hours of ischemia and 6 hours of reperfusion. Then, all animals were euthanized, and their right ovaries were removed. Ovarian tissues were examined for oxidants (malondialdehyde), antioxidants (total glutathione, superoxide dismutase, and catalase), and proinflammatory cytokines (nuclear factor kappa-B, tumor necrosis factor-alpha, interleukin 1 beta, and interleukin-6) analysis was performed. Tissues were examined histopathologically. Results: The ovarian tissue of the OIR, which underwent the I/R procedure, exhibited a significant increase in oxidant and proinflammatory cytokine levels, along with a decrease in antioxidant levels (P < .001). Ramipril suppressed the I/R-induced increase in oxidants and pro-inflammatory cytokines and the decrease in antioxidants (P < .001). Ramipril also attenuated I/R-induced histopathological damage in ovarian tissue (P < .05). Conclusion: Ramipril treatment may be a treatment strategy to protect ovarian tissue against oxidative and inflammatory damage of I/R. © 2023 Elsevier Inc.
Anahtar Kelimeler
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Ulug, Pasa | |
| dc.contributor.author | Nayki, Umit | |
| dc.contributor.author | Mammadov, Renad | |
| dc.contributor.author | Bulut, Seval | |
| dc.contributor.author | Tastan, Tugba Bal | |
| dc.contributor.author | Coban, Taha Abdulkadir | |
| dc.contributor.author | Suleyman, Halis | |
| dc.date.accessioned | 2026-10-18T20:26:50.001266122Z | |
| dc.date.available | 2026-10-18T20:26:50.001266122Z | |
| dc.date.issued | 2024 | |
| dc.description.abstract | Background: It is known that the increase in oxidants and proinflammatory cytokines, as well as the decrease in antioxidants, play a role in ovarian ischemia-reperfusion (I/R) injury. The antioxidant and anti-inflammatory properties of ramipril have been studied in various diseases. This study aims to investigate the effect of ramipril on I/R-induced ovarian damage in rats. Methods: Rats were divided into healthy (HG), sham (SG), ovary I/R (OIR), and ramipril + ovary I/R (ROIR) groups (n = 6/each group). One hour before the surgical procedures, ROIR was given 2 mg/kg ramipril. The lower abdomen of the SG, OIR, and ROIR was surgically opened. Right ovarian tissues of OIR and ROIR were subjected to 2 hours of ischemia and 6 hours of reperfusion. Then, all animals were euthanized, and their right ovaries were removed. Ovarian tissues were examined for oxidants (malondialdehyde), antioxidants (total glutathione, superoxide dismutase, and catalase), and proinflammatory cytokines (nuclear factor kappa-B, tumor necrosis factor-alpha, interleukin 1 beta, and interleukin-6) analysis was performed. Tissues were examined histopathologically. Results: The ovarian tissue of the OIR, which underwent the I/R procedure, exhibited a significant increase in oxidant and proinflammatory cytokine levels, along with a decrease in antioxidant levels (P < .001). Ramipril suppressed the I/R-induced increase in oxidants and pro-inflammatory cytokines and the decrease in antioxidants (P < .001). Ramipril also attenuated I/R-induced histopathological damage in ovarian tissue (P < .05). Conclusion: Ramipril treatment may be a treatment strategy to protect ovarian tissue against oxidative and inflammatory damage of I/R. © 2023 Elsevier Inc. | |
| dc.identifier.doi | 10.1016/j.transproceed.2023.11.016 | |
| dc.identifier.eissn | 1873-2623 | |
| dc.identifier.endpage | 222 | |
| dc.identifier.issn | 0041-1345 | |
| dc.identifier.issue | 1 | |
| dc.identifier.pmid | 38218697 | |
| dc.identifier.scopus | 2-s2.0-85182568884 | |
| dc.identifier.startpage | 215 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/ebyu/11836 | |
| dc.identifier.volume | 56 | |
| dc.identifier.wos | WOS:001188078600001 | |
| dc.language.iso | en | |
| dc.publisher | Elsevier Inc. | |
| dc.relation.ispartof | Transplantation Proceedings | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Animals | |
| dc.subject | Antioxidants | |
| dc.subject | Cytokines | |
| dc.subject | Female | |
| dc.subject | Ischemia | |
| dc.subject | Malondialdehyde | |
| dc.subject | Oxidants | |
| dc.subject | Oxidative Stress | |
| dc.subject | Ramipril | |
| dc.subject | Rats | |
| dc.subject | Rats, Wistar | |
| dc.subject | Reperfusion | |
| dc.subject | Reperfusion Injury | |
| dc.subject | catalase | |
| dc.subject | glutathione | |
| dc.subject | immunoglobulin enhancer binding protein | |
| dc.subject | interleukin 1beta | |
| dc.subject | interleukin 6 | |
| dc.subject | malonaldehyde | |
| dc.subject | superoxide dismutase | |
| dc.subject | tumor necrosis factor | |
| dc.subject | antioxidant | |
| dc.subject | cytokine | |
| dc.subject | oxidizing agent | |
| dc.subject | animal experiment | |
| dc.subject | animal model | |
| dc.subject | animal tissue | |
| dc.subject | antiinflammatory activity | |
| dc.subject | antioxidant activity | |
| dc.subject | Article | |
| dc.title | Protective Effect of Ramipril Against Oxidant and Proinflammatory Cytokine Damage Induced by Ischemia-Reperfusion in Ovarian Tissue in Rats | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| rdl.citation.scopus | 5 | |
| rdl.citation.wos | 5 | |
| rdl.department | Department of Gynecology and Obstetrics, School of Medicine, Erzincan Binali Yıldırım University, Erzincan, Turkey. Electronic address: pasaulug@hotmail.com. | Department of Gynecology and Obstetrics, School of Medicine, Erzincan Binali Yıldırım University, Erzincan, Turkey. | Department of Pharmacology, School of Medicine, Erzincan Binali Yıldırım University, Erzincan, Turkey. | Department of Histology and Embryology, School of Medicine, Erzincan Binali Yıldırım University, Erzincan, Turkey. | Department of Medical Biochemistry, School of Medicine, Erzincan Binali Yıldırım University, Erzincan, Turkey. | |
| rdl.oa.status | gold | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | WOS | |
| rdl.source.index | PUBMED | |
| rdl.wos.index | Science Citation Index Expanded (SCI-EXPANDED) |
